Pantoprazol Kalceks (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Kalceks, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazol Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Kalceks is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Erosive esophagitis: accelerates mucosal healing and reduces risk of complications. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors. - Peptic ulcer disease: supports ulcer healing and prevents recurrence.

Pantoprazol Kalceks may cause a range of adverse reactions. Most are mild and resolve after continued therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools without blood. - Abdominal pain: cramping or discomfort. - Nausea: feeling of queasiness. - Flatulence: increased intestinal gas. - Constipation: infrequent, hard stools.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis with watery diarrhea. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Severe hypersensitivity: rash, angioedema, or anaphylaxis. - Osteoporotic fractures: increased risk with long‑term use. - Low magnesium (hypomagnesemia): muscle cramps, arrhythmias. - Liver enzyme elevation: signs of hepatic stress.

Before initiating therapy, consider the following safety measures: - Assess renal function: adjust use in severe renal impairment. - Evaluate hepatic status: use with caution in moderate liver disease. - Review concomitant medications: potential for interaction with drugs requiring gastric acidity. - Monitor long‑term therapy: assess need for continued use after 8‑12 weeks. - Pregnancy and lactation: weigh benefits against potential risks; consult a physician. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture.

Pantoprazole can affect the absorption and metabolism of several medicines. Review patient medication lists carefully.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption leading to therapeutic failure. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Methotrexate: reduced renal clearance; watch for toxicity. - Digoxin: slight increase in serum levels; assess for signs of toxicity.